Article
GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
Current Alzheimer research - 1 Apr 2009
Tian Jinzhou, Shi Jing, Zhang Leiming, Yin Junxiang, Hu Quan, Xu Yi, Sheng Shuli, Wang Pengwen, Ren Ying, Wang Rong, Wang Yongyan
Abstract excerpt
BACKGROUND: Accumulation of beta-amyloid peptide (Abeta) in the brain is a primary influence driving Alzheimer's disease (AD) pathogenesis. The disease process, including formation of neurofibrillary tangles containing tau protein, is proposed to result from an imbalance between production and clearance of Abeta. A major therapeutic strategy for AD should be to decrease deposition of Abeta by the inhibition of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
